LQD News 120.58 09/02/2014 05:14:38 Iboxx $ Invest Grade Corp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Iboxx $ Invest Grade Corp Bond Ishares (LQD) 120.58 $LQD

LQD: Large Inflows Detected at ETF
ETFChannel.com - Tue Aug 12, 9:56AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares iBoxx $ Investment Grade Corporate Bond ETF where we have detected an approximate $190.4 million dollar inflow...

LQD: ETF Inflow Alert
ETFChannel.com - Fri Jul 25, 10:13AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares iBoxx $ Investment Grade Corporate Bond ETF where we have detected an approximate $35.7 million dollar inflow...

2013 ETF Asset Report: Developed Markets Rule, Gold Falters - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Dec 26, 1:01PM CST
Which ETFs saw the biggest inflows (and outflows) during 2013?

SmarTrend Watching for Potential Pullback in Shares of iShares iBoxx Investment Grade Corporate Bond Fund After 1.47% Gain
Comtex SmarTrend(R) - Wed Sep 18, 4:23PM CDT
iShares iBoxx Investment Grade Corporate Bond Fund (AMEX:LQD) traded in a range yesterday that spanned from a low of $111.42 to a high of $113.71. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.44 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for iShares iBoxx Investment Grade Corporate Bond Fund to Potentially Pullback After Gaining 1.47% Yesterday
Comtex SmarTrend(R) - Wed Sep 18, 4:22PM CDT
iShares iBoxx Investment Grade Corporate Bond Fund (AMEX:LQD) traded in a range yesterday that spanned from a low of $111.42 to a high of $113.71. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.44 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Surprise! You Probably Own Some of Verizon's Bonds
Dan Caplinger, The Motley Fool - Motley Fool - Fri Sep 13, 2:53PM CDT
Bond investors who use ETFs for their fixed-income investing have largely focused on just one thing lately: the losses they've suffered as rising interest rates have caused bond fund prices to fall. Yet the more recent massive offering of $49 billion...

Are Bonds Too Cheap?
Robert Ciura, The Motley Fool - Motley Fool - Fri Aug 30, 12:10PM CDT
As the economy slowly recovers from the worst financial crisis in decades, it's getting likelier by the day that the Federal Reserve will soon wind down its stimulus programs. In an effort to boost the economy, the Fed embarked on initiatives such as...

Bull of the Day: Magellan (MMP) - Bull of the Day
Nick Kalivas - Zacks Investment Research - Sun Aug 18, 8:36AM CDT
Bull of the Day: Magellan (MMP) - Bull of the Day

What's Your PE Ratio? - Analyst Blog
Nick Kalivas - Zacks Investment Research - Tue Aug 13, 3:07PM CDT
Defending a PE ratio for the stock market is never easy. Here's some help to think through the process.

The Real Reason Pension Funds Can't Earn 8%
Dan Caplinger, The Motley Fool - Motley Fool - Mon Aug 05, 11:11AM CDT
The Detroit bankruptcy filing has raised concerns not just about workers and retirees within the city's pension system but about public pensions across the nation. With states like Illinois facing pension shortfalls numbering in the tens of...

S&P New High Fuel NorthCoast Retirement Portfolios
at Investor's Business Daily - Thu Aug 01, 5:35PM CDT
NorthCoast Asset Management's retirement portfolios saw impressive returns from some of its largest holdings during July. The Greenwich, Conn.-based firm uses iShares ETFs as building blocks to construct its four retirement portfolios. Here are some...

iShares Unveils 4 More Target Date Bond ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Jul 18, 8:07AM CDT
For investors looking for targeted bond exposure, these specific date bond funds could be worth a closer look.

iShares iBoxx Investment Grade Corporate Bond Fund Falls 1.27% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Jul 05, 4:16PM CDT
iShares iBoxx Investment Grade Corporate Bond Fund (AMEX:LQD) traded in a range yesterday that spanned from a low of $111.70 to a high of $112.43. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $113.08 on volume of 2.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares iBoxx Investment Grade Corporate Bond Fund Set to Possibly Rebound After Yesterday's Selloff of 1.27%
Comtex SmarTrend(R) - Fri Jul 05, 4:15PM CDT
iShares iBoxx Investment Grade Corporate Bond Fund (AMEX:LQD) traded in a range yesterday that spanned from a low of $111.70 to a high of $112.43. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $113.08 on volume of 2.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of iShares iBoxx Investment Grade Corporate Bond Fund After 1.27% Loss
Comtex SmarTrend(R) - Fri Jul 05, 4:15PM CDT
iShares iBoxx Investment Grade Corporate Bond Fund (AMEX:LQD) traded in a range yesterday that spanned from a low of $111.70 to a high of $112.43. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $113.08 on volume of 2.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Investors Continue to Flee Bonds - Real Time Insight
Todd Bunton - Zacks Investment Research - Thu Jun 27, 2:22PM CDT
When do you think we will start to see positive inflows back into bonds?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles